Amadeus invests in Inotec’s advanced woundcare technology - NATROX™

Amadeus Capital Partners, the global technology investor, has today announced an investment in Inotec AMD, a maker of mobile medical devices designed to heal chronic, hypoxic wounds that afflict millions of sufferers around the world every year. As more than 90% of wounds suffer from a lack of oxygen, the launch of NATROX™ addresses this serious concern with a simple, cost-effective application which treats a broad spectrum of chronic health problems.

Amadeus Capital Partners will bring investment and expertise to Inotec, based in Cambridge, UK, to enable the company to carry out large scale clinical trials outside the UK and to broaden the scope of application of its innovative NATROX™ family of products. The global investor in dynamic start-ups will also draw on its worldwide network to help Inotec establish commercial agreements and grow its presence internationally.

Inotec was established in 2005 by Professor Derek Fray from Cambridge University and Mel Vinton. It’s compact and wearable NATROX™ system, which is CE marked and FDA approved, provides a continuous supply of pure humidified oxygen to wounds. In preliminary trials, NATROX™ has been shown to reduce the size of chronic wounds substantially within weeks, with a large number of patients’ wounds reaching complete healing.

“Inotec’s proprietary technology has the potential to profoundly improve standards of care for hard-to-heal and chronic wounds, a large and growing market, which has not been disrupted since negative therapy (VAC) was launched in the ‘90s. Being small and portable, NATROX™ can be used at home as well as in hospital, alleviating pressure on stretched healthcare systems and materially improving quality of life for patients,” said Pierre Socha, Investment Manager, Amadeus Capital Partners.

Trevor Stanley, Inotec CEO, commented, “The global wound-care market is projected to grow to $18.3 billion globally in 2019, driven in part by changing life styles and ageing populations in many countries. There are some 400 million diabetes sufferers around the world, some 60 million of whom are likely to develop a lower limb ulcer. Amadeus’ investment will enable us to deliver advanced and highly effective oxygen-based wound-care technology across the world.”

Time to speak to the digital doctor: 62% of Brits have now used technology to access primary healthcare‏

Ordering repeat prescriptions, speaking to GPs online, attending video appointments  are the most popular ways patients are using tech -

AN OVERWHELMING number of UK patients are currently using technology to access doctor’s appointments and medication, according to new research into patient behaviours and the healthcare ecosystem.

62% of Britons have used technology to access healthcare, according to a study of 1,014 British adults carried out by on-demand video GP consultation service, PushDoctor.co.uk.

According to the data, ordering repeat prescriptions (29%) is currently the most popular way Britons are using technology to access healthcare services.

More than 1 in 5 (22%) have communicated with a GP online - e.g. via live chat, whilst 1 in 7 (17%) have already used video consultation services to speak to a GP.

Those aged 18-24 and 35-44 are driving adoption of these technologies.

Convenience is leading this step change, with almost one in three (30%) claiming they would consult a GP via video if it meant they could have an appointment when and where they wanted.

Meanwhile, 27% would do so if it meant they could have an immediate or same day appointment, and 1 in 4 (26%) if they couldn’t travel to their GP surgery.

Eren Ozagir, CEO and founder at PushDoctor.co.uk, said: “This report shows just how much technology is altering patient behaviours, and how widely this is now being accepted by those seeking to access primary care in a way more syncopated with people’s lives.

“This research also shows that the vast majority of all patients appreciate the need for innovations which make it quicker and more convenient to get expert medical advice. Ultimately, this comes down providing greater patient choice - enabling them to have more control over how and when they access their healthcare - which is something I’m sure most health professionals strive to offer their patients.”

Dr Adam Simon, chief medical officer at PushDoctor.co.uk, said: “Clearly there is significant demand amongst patients for new pathways to healthcare which work better for them, and are more in keeping with the ways they manage other areas of their lives. Such technologies are being gradually introduced into the healthcare industry the UK, but - looking at this data - there is a need to speed up this process.

“In introducing this greater level of convenience and choice, UK health providers will be better equipped to reach and help a greater number of patients, whilst bringing access to healthcare more in line with the ways other industries and services have modernised over the past five to 10 years.”

For more information, visit www.PushDoctor.co.uk or visit the App Store.

Top 5 Ways British Patients Are Using Technology to Access Primary Healthcare and GP Services;

1.    Order repeat prescriptions (29%)

2.    Attend a GP appointment via live chat (22%)

3.    Attend a video appointment with a GP (17%)

4.    Access medical records (16%)

5.    Buy non-prescription medication (15%)